Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | LEN | DOW |
|---|---|---|
| Price | $81.72 | $27.29 |
| Change today | ▲ 0.16% | ▼ 0.93% |
| Market cap | $19.69B | $19.71B |
| Return, 3 months | -5.6% | +2.1% |
| Return, year to date | -19.3% | +20.6% |
| Return, 1 year | -35.0% | +24.1% |
| P/E (TTM) | 15.5 | -14.9 |
| P/B | 0.9 | 1.2 |
| P/E percentile vs own 5y | 100th | 11th |
| Dividend yield | 2.45% | 5.13% |
| Revenue growth (YoY, latest qtr) | -8.7% | +19.7% |
| Net profit growth (YoY) | -52.4% | +200.1% |
| Gross margin | 13.8% | 9.9% |
| Operating margin | 5.6% | 3.7% |
| Net margin | 4.1% | -3.1% |
| Return on equity | 5.9% | -7.9% |
| Analyst target vs. price | -3.1% | +27.2% |
| Analyst buy share | 8% | 33% |
| RSI (14) | 49 | 35 |
| 30-day volatility | 35.8% | 30.2% |
| Max drawdown, 1 year | -41.7% | -34.8% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Sell | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
